X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26994) 26994
Newsletter (493) 493
Magazine Article (93) 93
Newspaper Article (57) 57
Book Chapter (39) 39
Dissertation (22) 22
Streaming Video (8) 8
Conference Proceeding (4) 4
Journal / eJournal (4) 4
Book Review (3) 3
Transcript (3) 3
Publication (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19183) 19183
male (12105) 12105
female (11774) 11774
methylprednisolone - therapeutic use (10105) 10105
methylprednisolone (9294) 9294
adult (7981) 7981
middle aged (6956) 6956
methylprednisolone - administration & dosage (6808) 6808
animals (4511) 4511
treatment outcome (3864) 3864
aged (3770) 3770
corticosteroids (3592) 3592
adolescent (3136) 3136
methylprednisolone - pharmacology (2601) 2601
drug therapy, combination (2571) 2571
anti-inflammatory agents - therapeutic use (2525) 2525
surgery (2523) 2523
child (2466) 2466
glucocorticoids - therapeutic use (2383) 2383
clinical neurology (2274) 2274
immunosuppressive agents - therapeutic use (2067) 2067
time factors (1982) 1982
rats (1851) 1851
methylprednisolone - adverse effects (1837) 1837
therapy (1790) 1790
glucocorticoids - administration & dosage (1720) 1720
medicine, general & internal (1666) 1666
follow-up studies (1647) 1647
steroids (1636) 1636
anti-inflammatory agents - administration & dosage (1618) 1618
transplantation (1569) 1569
retrospective studies (1566) 1566
magnetic resonance imaging (1504) 1504
immunology (1495) 1495
child, preschool (1359) 1359
pediatrics (1342) 1342
care and treatment (1332) 1332
rheumatology (1312) 1312
acute disease (1245) 1245
neurosciences (1232) 1232
dose-response relationship, drug (1219) 1219
prospective studies (1150) 1150
methylprednisolone - analogs & derivatives (1119) 1119
children (1114) 1114
medicine & public health (1101) 1101
research (1069) 1069
pharmacology & pharmacy (1052) 1052
prednisone - therapeutic use (1042) 1042
dexamethasone (1040) 1040
injections, intravenous (1039) 1039
glucocorticoids (986) 986
hematology (981) 981
drug administration schedule (979) 979
drug therapy (957) 957
recurrence (947) 947
prognosis (946) 946
administration, oral (928) 928
disease (916) 916
diagnosis, differential (906) 906
cyclophosphamide - therapeutic use (905) 905
biopsy (882) 882
diagnosis (864) 864
health aspects (861) 861
urology & nephrology (861) 861
young adult (845) 845
inflammation (836) 836
management (836) 836
azathioprine - therapeutic use (835) 835
ophthalmology (825) 825
analysis (822) 822
multiple sclerosis (813) 813
infusions, intravenous (805) 805
cyclophosphamide (801) 801
infant (800) 800
oncology (797) 797
risk factors (788) 788
adrenal cortex hormones - therapeutic use (786) 786
disease models, animal (786) 786
prednisolone (781) 781
pulse therapy, drug (779) 779
kidney transplantation (763) 763
immunosuppression (762) 762
double-blind method (760) 760
immunosuppressive agents - administration & dosage (760) 760
prednisolone - therapeutic use (759) 759
double-blind (756) 756
cyclosporine - therapeutic use (753) 753
patients (752) 752
aged, 80 and over (745) 745
prednisolone - administration & dosage (715) 715
combined modality therapy (706) 706
dosage and administration (691) 691
abridged index medicus (686) 686
spinal cord injury (686) 686
dogs (676) 676
orthopedics (671) 671
severity of illness index (660) 660
cyclophosphamide - administration & dosage (643) 643
high-dose methylprednisolone (626) 626
tomography, x-ray computed (621) 621
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24592) 24592
Japanese (1021) 1021
German (699) 699
French (640) 640
Spanish (397) 397
Italian (256) 256
Chinese (213) 213
Russian (153) 153
Portuguese (129) 129
Polish (120) 120
Korean (50) 50
Turkish (46) 46
Danish (44) 44
Czech (37) 37
Hungarian (32) 32
Dutch (26) 26
Norwegian (21) 21
Swedish (15) 15
Finnish (14) 14
Bulgarian (11) 11
Croatian (11) 11
Serbian (11) 11
Romanian (8) 8
Hebrew (7) 7
Afrikaans (5) 5
Lithuanian (3) 3
Persian (3) 3
Slovak (3) 3
Ukrainian (3) 3
Slovenian (2) 2
Arabic (1) 1
Belarusian (1) 1
Bosnian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 16, pp. 1671 - 1684
Journal Article
Journal of neurotrauma, ISSN 1557-9042, 2015, Volume 32, Issue 21, pp. 1674 - 1683
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 2018, Volume 84, Issue 5, pp. 1020 - 1028
Aims Intravenous high‐dose free methylprednisolone (MP) hemisuccinate is the primary treatment for an acute relapse in relapsing–remitting multiple sclerosis.... 
methylprednisolone | liposomes | multiple sclerosis | RELAPSES | COMPLEMENT | ACTIVATION | PLACEBO | GLUCOCORTICOIDS | INTRAVENOUS METHYLPREDNISOLONE | MODEL | PHARMACOKINETICS | THERAPEUTIC-EFFICACY | PHARMACOLOGY & PHARMACY | Methylprednisolone - pharmacokinetics | Humans | Male | Methylprednisolone - adverse effects | Polyethylene Glycols - chemistry | Healthy Volunteers | Dose-Response Relationship, Drug | Osteocalcin - blood | Drug Therapy, Combination - adverse effects | Anti-Inflammatory Agents - adverse effects | Delayed-Action Preparations - pharmacology | Delayed-Action Preparations - pharmacokinetics | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Adrenocorticotropic Hormone - blood | Methylprednisolone - chemistry | Double-Blind Method | Drug Administration Schedule | Drug Compounding - methods | Blood Glucose | Liposomes - adverse effects | Anti-Allergic Agents - therapeutic use | Cross-Over Studies | Liposomes - chemistry | Anti-Inflammatory Agents - chemistry | Methylprednisolone - pharmacology | Lymphocyte Count | Glutathione - chemistry | Clemastine - therapeutic use | Liposomes - pharmacology | Liposomes - pharmacokinetics | Antihistamines | Multiple sclerosis | Thiols | Corticosteroids | Lymphocytes | Analysis | ACTH | Methylprednisolone | Steroids | Index Medicus | Therapeutics
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2015, Volume 2015, Issue 8, p. CD001430
Background Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost... 
Acute Disease | Dexamethasone | Injections, Intravenous | Glucocorticoids | Administration, Oral | Optic Neuritis | Prednisone | Methylprednisolone | Visual Acuity | Randomized Controlled Trials as Topic | Optic nerve disease | Anti‐Inflammatory Agents | Eyes & vision | Medicine General & Introductory Medical Sciences | Contrast Sensitivity | TREATMENT-TRIAL | Humans | Male | FOLLOW-UP | RECOVERY | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE METHYLPREDNISOLONE | MULTIPLE-SCLEROSIS | Female | Anti-Inflammatory Agents [administration & dosage; therapeutic use] | VISUAL-FIELD PROFILE | Prednisone [administration & dosage; therapeutic use] | Methylprednisolone [administration & dosage; therapeutic use] | Dexamethasone [administration & dosage; therapeutic use] | Contrast Sensitivity [drug effects] | Optic Neuritis [drug therapy] | INJECTION | EXPERIENCE | Visual Acuity [drug effects] | Glucocorticoids [administration & dosage; therapeutic use] | FUNCTION QUESTIONNAIRE | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Methylprednisolone - therapeutic use | Dexamethasone - therapeutic use | Visual Acuity - drug effects | Optic Neuritis - drug therapy | Contrast Sensitivity - drug effects | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2017, Volume 318, Issue 5, pp. 432 - 442
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 10, p. CD001446
Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be... 
Guillain‐Barre Syndrome | Glucocorticoids | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Child health | Guillain‐Barré syndrome | Anti‐Inflammatory Agents | Adrenocorticotropic Hormone | Medicine General & Introductory Medical Sciences | Prednisolone | Corticosteroid treatment | GLOMERULONEPHRITIS | Methylprednisolone [administration & dosage; therapeutic use] | STEROIDS | Humans | Prednisolone [administration & dosage; therapeutic use] | Adrenocorticotropic Hormone [administration & dosage;therapeutic use] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | METHYLPREDNISOLONE | Guillain-Barre Syndrome [drug therapy] | TRIAL | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | PREDNISONE | THERAPY | STANDARD TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | Anti-Inflammatory Agents [administration & dosage;therapeutic use] | Adult | Glucocorticoids [administration & dosage; therapeutic use] | Child | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisolone - administration & dosage | Methylprednisolone - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Guillain-Barre Syndrome - drug therapy | Adrenocorticotropic Hormone - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisolone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 7, pp. e0130442 - e0130442
The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of... 
MYELIN BASIC-PROTEIN | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | MULTIPLE-SCLEROSIS | BARRIER PERMEABILITY | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | DOSE INTRAVENOUS METHYLPREDNISOLONE | SPINAL-CORD | BLOOD-BRAIN | VASCULAR-PERMEABILITY | Encephalomyelitis, Autoimmune, Experimental - metabolism | Nanoparticles - chemistry | Prodrugs - chemistry | Neurodegenerative Diseases - drug therapy | Apolipoproteins E - metabolism | Tissue Distribution | Inflammation - metabolism | Methylprednisolone Hemisuccinate - chemistry | Cyclic N-Oxides - pharmacology | Inflammation - drug therapy | Amyloid beta-Peptides - metabolism | Anti-Inflammatory Agents - pharmacokinetics | Disease Models, Animal | Multiple Sclerosis - metabolism | Anti-Inflammatory Agents - pharmacology | Methylprednisolone Hemisuccinate - pharmacokinetics | Methylprednisolone Hemisuccinate - pharmacology | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Neurodegenerative Diseases - metabolism | Cyclic N-Oxides - pharmacokinetics | Cyclic N-Oxides - chemistry | Liposomes - chemistry | Animals | Anti-Inflammatory Agents - chemistry | Prodrugs - pharmacokinetics | Mice | Drug Delivery Systems - methods | Prodrugs - pharmacology | Multiple Sclerosis - drug therapy | Drugs | Nervous system | Degeneration | Peptides | Apolipoproteins | Health aspects | Corticoids | Animal models | Multiple sclerosis | Drug delivery systems | Spinal cord | Nuclear magnetic resonance--NMR | Disease | Laboratories | Toxicity | Neuropathology | Biochemistry | Neurosurgery | Nitroxide | Drug development | Methylprednisolone | Adoptive transfer | Medical schools | Antioxidants | Blood-brain barrier | Apolipoprotein E | Drug dosages | Alzheimer's disease | Medical research | Effectiveness | Free radicals | Neurodegenerative diseases | Medical treatment | Pharmacology | Permeability | Chemical compounds | Experimental allergic encephalomyelitis | Diseases | Neurological diseases | Neurology | Brain research | β-Amyloid | Liposomes | Pharmacokinetics | Molecular biology | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article